Results 251 to 260 of about 120,857 (300)

Gender Differences in Ischemic Cardiomyopathy

Current Atherosclerosis Reports, 2018
Cardiovascular disease remains the leading cause of death among women globally, majority of which are due to ischemic heart disease. Despite the recent advances in the overall management of CVD, there are unique challenges in the diagnosis and management of women as well as poorer outcomes.Women with ischemic cardiomyopathy experience significant ...
Laura, Divoky, Anbukarasi, Maran, Bhavadharini, Ramu   +2 more
openaire   +2 more sources

Chagas cardiomyopathy and ischemic stroke

Expert Review of Cardiovascular Therapy, 2006
American trypanosomiasis, known as Chagas disease is a major cause of cardiomyopathy in South America. Irreversible damage to the heart can appear 10-20 years after chagasic infection. The relationship between Chagas cardiomyopathy and ischemic stroke has been reviewed.
openaire   +2 more sources

Ischemic cardiomyopathy: Pathophysiologic mechanisms

Progress in Cardiovascular Diseases, 1990
SCHEMIC cardiomyopathy is an anatomic condition emanating from a sustained imbalance between oxygen supply and demand of the heart that, in turn, leads to myocyte loss with resultant myocardial scarring and ventricular failure. Cell loss can occur as a result of focal narrowing or occlusion of the main coronary arteries by atherosclerosis, spasm of the
P, Anversa, E H, Sonnenblick
openaire   +2 more sources

The Arrhythmogenic Substrate in Ischemic and Non-ischemic Cardiomyopathies

2001
For the mechanistic study of arrhythmias in clinical practice the terms “arrhythmogenic substrate”, “initiating factor” and “modulating factors” have been introduced.1 We define the substrate as “a pre-existing condition that forms a prerequisite for the induction of an arrhythmia”.
Coronel, R., Baartscheer, A., Rademaker, J. M. E., Vermeulen, J. T., de Bakker, J. M. T.   +4 more
openaire   +2 more sources

Functional morphology of ischemic cardiomyopathy

Arkhiv patologii, 2014
To show that ischemic cardiomyopathy (ICM) that is generally believed to be a variant of chronic heart disease (CHD) and an analogue of chronic heart failure is an initial stage and the background of all further forms of CHD.Sixty cardiac biopsies obtained from patients during aortocoronary bypass surgery for CHD and myocardia from 55 rabbits in which ...
V S, Paukov, A S, Gavrish, V A, Krichkevich   +2 more
openaire   +2 more sources

A treatment algorithm for ischemic cardiomyopathy

Vascular Pharmacology
Treatment of ischemic cardiomyopathy has been the focus of increased attention by cardiologists due to recent evidence of an important outcome study comparing percutaneous coronary intervention (PCI) plus optimal medical treatment vs optimal medical treatment alone, concluding for the futility of myocardial revascularization by PCI.
Raffaele, De Caterina, Riccardo, Liga
openaire   +2 more sources

Coronary revascularization in ischemic cardiomyopathy

Surgical Clinics of North America, 2004
This article first discusses coronary artery disease, including left-ventricular dysfunction, hibernating myocardium, the relationship between stunning, hibernation, and heart failure, and molecular mechanisms underlying myocardial hibernation. Left ventricular function and the prognosis and pathophysiology of left-ventricular dysfunction are then ...
openaire   +2 more sources

Ischemic Cardiomyopathy

Southern Medical Journal, 1972
G E, Burch, T D, Giles
openaire   +4 more sources

The efficacy of revascularization in ischemic cardiomyopathy

Progress in Cardiovascular Diseases
Ischemic cardiomyopathy (ICM) is characterized by myocardial dysfunction due to myocardial ischemia, associated with the presence of significant coronary artery disease (CAD). We provide a comprehensive review of the current evidence for coronary revascularization in ICM, including consideration of the different modalities of coronary artery bypass ...
Kais, Hyasat, Chieh-Shou, Su, Ajay J, Kirtane, Margaret, McEntegart   +3 more
openaire   +2 more sources

Surgical options in ischemic cardiomyopathy.

Italian heart journal : official journal of the Italian Federation of Cardiology, 2004
The prevalence of ischemic dilated cardiomyopathy in western countries is increasing despite improvements in prevention, diagnosis, and treatment of cardiovascular disease. The management of patients with coronary artery disease and severe left ventricular dysfunction continues to be challenging and the mortality rate with medical therapy alone in this
DE BONIS , MICHELE, Lapenna E, Ficarra E, La Canna G, Verzini A, Pagliaro M, Castiglioni A, Maisano F, Torracca L, Benussi S, ALFIERI , OTTAVIO   +10 more
openaire   +3 more sources